Solta Medical Acquired By Valeant Pharmaceuticals
Hayward-based Solta Medical has been acquired by Valeant Pharmaceuticals, in a deal worth approximately $250M. Valeant said it will pay $2.92 per share in cash for Solta, which develops aesthetic medicine medical devices, including RF devices for skin tightening. Solta hd revenues of approximately $145M in 2012. Solta was advised by Piper Jaffray & Co. and Fenwick & West LLP. Valeant was advised by Skadden, Arps, Slate, Meagher & Flom LLP.
posted on Monday, December 16, 2013
Related companies:
SOLTA MEDICAL INC
Related stories:
> Solta Medical Buys Sound Surgical Technologies
> Solta Medical Completes Sound Surgical Technologies Buy
> Solta Medical Gets $22M In Credit Facility
> Solta Medical Buys CLRS Technology
> Solta Medical Expands Credit Line
silicontap.com Home